Biogen Inc 's Revenue in the fiscal year 2025 $ 9,890.60 millions
Biogen Inc 's Revenue in the fiscal year 2024 $ 9,675.90 millions
Biogen Inc 's Revenue in the fiscal year 2023 $ 9,835.60 millions
Biogen Inc 's Revenue in the fiscal year 2022 $ 10,173.40 millions
Biogen Inc 's Revenue in the fiscal year 2021 $ 10,981.70 millions
BIIB Revenue third quarter 2026 Y/Y Growth Comment
Biogen Inc achieved in the third quarter 2026, above Company average Revenue increase of 10.63% year on year, to $ 2,804.10 millions.
Looking into third quarter 2026 results within Biotechnology & Pharmaceuticals industry 41 other companies have achieved higher Revenue growth. While Biogen Inc ' s Revenue growth of 10.63% ranks overall at the positon no. 2642 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Biogen Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
80.67 %
2.78 %
-15.51 %
(March 31, 2004)
BIIB's III. Quarter Q/Q Revenue Comment
Biogen Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.49% quarter on quarter, to $ 2,804.10 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.19% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 896.
Biogen Inc achieved in the III. Quarter 2026 below company average Revenue growth of 2.49% quarter on quarter, to $ 2,804.10 millions.
III. Quarter 2026 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the -4.19% in the III. Quarter a year ago.
Within Biotechnology & Pharmaceuticals industry 18 other companies have achieved higher Revenue quarter on quarter growth. While Biogen Inc 's Revenue growth quarter on quarter, overall rank is 896.
Biogen Inc 's 12 Months Revenue Growth Year on Year
Although Biogen Inc 's Annual Revenue growth year on year were below company's average 8.36% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.3% year on year, from 0.31% in Jun 30 2026.
In the Healthcare sector 355 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 356 to 2474.
Although Biogen Inc 's Annual Revenue growth year on year were below company's average 8.36% , Revenue announced in the Sep 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 2.3% year on year, from 0.31% in Jun 30 2026.
In the Healthcare sector 355 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 356 to 2474.
About Biogen Inc Revenue Growth Rates (BIIB), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
18.41%